Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-39
SponsorZeba Ahmad, Ph.D.

About this trial

The goal of this study is to develop a virtual group intervention to address post-traumatic stress related to cancer in young adult cancer survivors (YACs, aged 18-39). The study team will do this by integrating evidence-guided treatments and expert clinician feedback (N=10) on the content, delivery, and structure of the intervention. Next, the study team will refine this intervention through a pilot trial with a group of YACs (N=80).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Currently aged between 18 - 39;

Currently receiving or having completed treatment for cancer at the Mass General Cancer Institute within the past 5 years;

Reporting a score denoting at least mild symptoms of PTSD on the Post-traumatic Stress Checklist 5 (PCL-5);

English-speaking;

Disqualifiers

Unable to provide verbal consent

Reporting active symptoms of psychosis that preclude safe participation.

Trial design

Design model

Single group

Treatments tested in this trial

  • Psychosocial Intervention for Cancer-Related Post-Traumatic Stress in Young Adults

    Behavioral

    A new group-based virtual intervention to address post-traumatic stress related to cancer in YACs, integrating evidence-guided treatments from Cognitive Processing Therapy and Mind-Body Resiliency interventions.

Treatment groups

80 Participants
are divided into 1 treatment group
Group A: Psychosocial Intervention for Cancer-Related Post-Traumatic Stress in Young AdultsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll

Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.

Time frame
Post-treatment completion (enrollment to treatment completion is approximately 3 months)
2

Intervention Feasibility: Proportion of Participants Completing the Program

Percent of enrolled participants who complete the program, defined as completing 6 out of 8 sessions.

Time frame
Post-treatment completion (enrollment to treatment completion is approximately 3 months)
3

Intervention Acceptability

Acceptability will be assessed by the Client Satisfaction Questionnaire (CSQ-8). The intervention study will be considered acceptable if ≥80% of participants rate it as acceptable (defined as a CSQ-8 score ≥20).

Time frame
Post-treatment completion (enrollment to treatment completion is approximately 3 months)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Zeba Ahmad, Ph.D.

Lead sponsor

Massachusetts General Hospital

Sponsor institution

American Cancer Society, Inc.

Collaborator

This trial is not recruiting at the moment. You can still explore other options: